Timmermann, A <br/><br/>
Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.  [electronic resource] 

 -  FEBS letters  Feb 2000 
 - 120-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-5793 
<br/><br/><label>Standard No.: </label>10.1016/s0014-5793(00)01205-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD--chemistry<br/>Binding Sites<br/>COS Cells<br/>Ciliary Neurotrophic Factor--pharmacology<br/>Cytokine Receptor gp130<br/>Dimerization<br/>Epitopes--analysis<br/>Growth Inhibitors--pharmacology<br/>Interleukin-6--pharmacology<br/>Leukemia Inhibitory Factor<br/>Lymphokines--pharmacology<br/>Membrane Glycoproteins--chemistry<br/>Models, Molecular<br/>Mutagenesis, Site-Directed<br/>Oncostatin M<br/>Peptides--pharmacology<br/>Point Mutation<br/>Protein Structure, Secondary<br/>Receptors, Cytokine--chemistry<br/>Receptors, OSM-LIF<br/>Receptors, Oncostatin M<br/>Recombinant Proteins--chemistry<br/>Signal Transduction--physiology<br/>Transfection